Sort
78,016 grants matching “breast cancer”
Genomewide association in early-onset breast cancer
$754,460Habibul Ahsan · University Of Chicago · U01 · FY2010 · CA
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family Registry
$754,456Esther M John · Cancer Prevention Instit Of California · R01 · FY2014 · CA
Communication-based Strategies to Eliminate Cancer Disparities
$754,438Matthew W. Kreuter · Washington University · P50 · FY2012 · CA
SHCC MU NCORP
$754,181Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2018 · CA
Inflammation and Colorectal Neoplasia
$754,094Andrew T Chan · Massachusetts General Hospital · R01 · FY2016 · CA
Monitoring tumor subclonal heterogeneity over time and space
$754,072Gabor T Marth · University Of Utah · U24 · FY2018 · CA
OPTIMIZING TREATMENT FOR NF1-DEFICIENT METASTATIC ER+ BREAST CANCERS
$753,826Baylor College Of Medicine · · FY2021 · Defense Health Agency
TARGETING REPLICATION STRESS IN TRIPLE-NEGATIVE BREAST CANCER
$753,749Yale Univ · · FY2022 · Department of the Army
Integrated Biomarkers to Characterize Breast Cancer Risk
$753,717Laura J Esserman · University Of California, San Francisco · U01 · FY2007 · CA
Immune diagnostics and vaccine targets: breast cancer antigens from mice to women
$753,681Mary L. Disis · University Of Washington · U01 · FY2012 · CA
MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM
$753,649Joseph Sparano · Montefiore Medical Center (Bronx, Ny) · UG1 · FY2019 · CA
In Vivo Multiphoton Based Imaging of Complex Cancer Cell Behavior
$753,636Vladislav Verkhusha · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · CA
Targeting Neuroblastoma with armed T cells
$753,575Lawrence G Lum · Wayne State University · R01 · FY2015 · CA
Prophytactic surgery in carriers of BRCA 1/2 mutations
$753,481Timothy R Rebbeck · University Of Pennsylvania · R01 · FY2006 · CA
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$753,460Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent
$753,394Charite Nicolette Ricker · University Of Southern California · R01 · FY2024 · CA
Protein Tyrosine Dephosphorylation & Signal Transduction
$753,375Nicholas K Tonks · Cold Spring Harbor Laboratory · R01 · FY2019 · CA
Cell-Surface Interactions in Pathogenesis
$753,334Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (3 of 3)
$753,044Baqar A Husaini · Tennessee State University · U54 · FY2012 · CA
TREATEMENT AND PREVENTION OF BREAST CANCER USING MULTIFUNCTIONAL INHIBITORS OF CHOLESTERAL BIOSYNTHESIS
$752,985University Of Missouri System · · FY2012 · Department of Defense
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)
$752,914Yan Xu · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · HL
A Multimodal Imaging System and Targeted Nanoprobes for Image-Guided Treatment of Breast Cancer
$752,876Huabei Jiang · University Of Florida · R01 · FY2016 · EB
Nonclinical development of Nervelight, an intra-operative peripheral nerve imaging agent
$752,754Stephen B Kahl · Manzanita Pharmaceuticals, Inc. · R44 · FY2018 · CA
Rewiring of regulatory networks in breast cancer by transcription factor isoforms
$752,706Marc Vidal · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Characterization of Cancer Stem Cells
$752,616William Farrar · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA